読み込み中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新データ
$4.15
$0.00 · 0.00%
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
前日終値
$4.15
$0.00 · 0.00%
日中の時刻はETです。市場データは遅延する場合があります。
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
日中レンジ
現在 $4.15
52週レンジ
現在 $4.15
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
67
割安
センチメント
54
まちまち
リスク
73
高リスク
モメンタム
54
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
日中レンジ
現在 $4.15
52週レンジ
現在 $4.15
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 1785.87万 USD | 2302.45万 USD | 3230.87万 USD | 4014.32万 USD | 4798.2万 USD |
| 売上原価 | 1155.76万 USD | 1695.26万 USD | 2199.36万 USD | 1825.18万 USD | 2265.59万 USD |
| 粗利益 | 630.12万 USD | 607.19万 USD | 1031.51万 USD | 2189.13万 USD | 2532.62万 USD |
| 研究開発 | 67.18万 USD | 303.11万 USD | 485.85万 USD | 762.33万 USD | 546.57万 USD |
| 販売・一般管理 | 800.24万 USD | 1044.44万 USD | 900.09万 USD | 2129.5万 USD | 627.04万 USD |
| 営業費用 | 921.71万 USD | 1409.17万 USD | 1384.19万 USD | 2891.08万 USD | 1173.6万 USD |
| 支払利息 | 23.2万 USD | 27.82万 USD | 15.68万 USD | 16.24万 USD | 10.16万 USD |
| 減価償却費と償却費 | 51.74万 USD | 48.57万 USD | 50.88万 USD | 53.39万 USD | 44.69万 USD |
| 営業利益 | −291.59万 USD | −801.98万 USD | −352.68万 USD | −701.94万 USD | 1359.01万 USD |
| 純利益 | −367.21万 USD | −872.73万 USD | −616.31万 USD | −873.66万 USD | 1132万 USD |
会社概要が更新されました 2026年10月11日.
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
